tiprankstipranks
Mirum Pharmaceuticals (MIRM)
NASDAQ:MIRM
US Market
MIRM
Mirum Pharmaceuticals
RESEARCH TOOLSreports
Want to see MIRM full AI Analyst Report?

Mirum Pharmaceuticals (MIRM) Income Statement

754 Followers

Mirum Pharmaceuticals Income Statement

Last quarter (Q1 2026), Mirum Pharmaceuticals's total revenue was $159.88M, an increase of 43.28% from the same quarter last year. In Q1, Mirum Pharmaceuticals's net income was $-790.15M. See Mirum Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 521.31M$ 336.89M$ 186.37M$ 77.06M$ 19.14M
Gross Profit
$ 420.73M$ 255.25M$ 139.34M$ 64.69M$ 17.23M
Operating Expenses
$ 443.21M$ 342.85M$ 248.49M$ 195.91M$ 190.65M
Depreciation and Amortization
$ 24.24M$ 23.63M$ 10.83M$ 3.24M$ 975.00K
EBITDA
$ 17.21M$ -48.97M$ -136.49M$ -122.85M$ -65.39M
Operating Income
$ -22.14M$ -87.61M$ -109.15M$ -131.22M$ -173.41M
Other Income/Expenses
$ 709.00K$ 694.00K$ -53.27M$ -10.85M$ 89.46M
Pretax Income
$ -21.43M$ -86.91M$ -162.42M$ -142.07M$ -83.95M
Net Income
$ -23.36M$ -87.94M$ -163.41M$ -135.66M$ -83.99M
Per Share Metrics
Basic EPS
$ -0.47$ -1.85$ -4.00$ -4.01$ -2.77
Diluted EPS
$ -0.47$ -1.85$ -4.00$ -4.02$ -2.77
Weighted Average Shares Outstanding
 50.20M 47.52M 40.89M 33.84M 30.32M
Weighted Average Shares Outstanding (Diluted)
 50.20M 47.52M 40.89M 33.98M 30.32M
Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History